FDA Warns Hospira Again, This Time in India

Beleaguered Hospira has received an FDA warning letter following an inspection at the company’s India plant
June 5, 2013
Hospira has received another warning letter from the US FDA following an inspection at the company’s India plant in October 2012. Read the full story
Sign up for our eNewsletters
Get the latest news and updates

Related

Fujifilm Biotechnologies to leverage downstream purification system at UK site
AI usage in pharma supply chain is moving from pilots to practical deployment: report
AI Compliance in Life Sciences: 5 Essentials
Sponsored
Medical Professionals' Confidence in Products: New Research
Sponsored